Andrade, Z.A., Pehoto, E., Guerret, S. & Grimaud, J.A. (1992) Hepatic connective tissue changes in hepatosplenic schistosomiasis. Human Pathology 23, 566–573.
Attallah, A.M., El Masry, S., Ismail, H., Attia, H., Abdel Aziz, M., Shehatta, A., Tabll, A., Soltan, A. & El Waseef, A. (1998) Immunochemical purification and characterization of a 74.0 kDa Schistosoma mansoni antigen. Journal of Parasitology 84, 301–306.
Attallah, A.M., Attia, H., El-Nashar, E., Nawar, A., Abdel Kader, K., Ismail, H. & El Ebeidy, G. (1999a) Induction of resistance against Schistosoma mansoni infection by passive transfer of an IgG2a monoclonal antibody. Vaccine 17, 2306–2310.
Attallah, A.M., Attia, H., Ismail, H., Yones, E., El-Nashar, E., Elbakry, K.A., Tabll, A., Saad, A. & Soltan, A. (1999b) Vaccination against S. mansoni infection using 74-kDa Schistosoma protein antigen. Vaccine 17, 2786–2791.
Bergquist, N.R. & Colley, D.G. (1998) Schistosomiasis vaccines: research to development. Parasitology Today 14, 99–104.
Boros, D.L. (1989) Immunopathology of Schistosoma mansoni infection. Clinical Microbiology Reviews 2, 250–269.
Capron, A., Dessaint, J.P., Capron, M., Ouma, J.H. & Butterworth, A.E. (1987) Immunity to schistosomes: progress toward vaccine. Science 238, 1067–1072.
Capron, A., Capron, M. & Riveau, G. (2002) Vaccine development against schistosomiasis from concepts to clinical trials. British Medical Bulletin 62, 139–148.
Da Silva, L.C. & Ferri, R.C. (1968) Schistosoma mansoni homogenate for active immunization of mice. American Journal of Tropical Medicine and Hygiene 17, 367–371.
Eberl, M., Langermans, J.A., Frost, P.A., Vervenne, R.A., van Dam, G.J., Deelder, A.M., Thomas, A.W., Coulson, P.S. & Wilson, R.A. (2001) Cellular and humoral immune responses and protection against schistosomes induced by a radiation-attenuated vaccine in chimpanzees. Infection and Immunity 69, 5352–5362.
Grzych, J.M., Grezel, D., Xu, C.B., Neyrinck, J.L., Capron, M., Ouma, J.H., Butterworth, A.E. & Capron, A. (1993) IgA antibodies to a protective antigen in human Schistosoma mansoni. Journal of Immunology 150, 527–535.
Harn, D.A., Quinn, J.J., Cianci, C.M. & Ko, A.I. (1987) Evidence that a protective membrane epitope is involved in early but not late phase immunity in Schistosoma mansoni. Journal of Immunology 138, 1571–1576.
Harn, D.A., Gu, W., Oligino, L.D., Mitsuyama, M., Gerbermichael, A. & Richter, D. (1992) A protective monoclonal antibody specifically recognizes and alters the catalytic activity of schistosome triose-phosphate isomerase. Journal of Immunology 148, 562–567.
Hirsch, C., Carvalho-Queiroz, C., Franco, G.R., Pena, S.D.J., Simpson, A.J.G. & Goes, M.A. (1997) Evidentiation of paramyosin (Sm-97) as a modulating antigen on granulomatous hypersensitivity to S. mansoni eggs. Memorias do Instituto Oswaldo Cruz 92, 663–667.
Lowry, O.H., Rosenbrough, N.J., Farr, A.L. & Randall, R.J. (1951) Protein measurement with folin-phenol reagent. Journal of Biological Chemistry 193, 265–275.
Ohmae, H., Tanaka, M., Nara, T., Utsunomiyn, H., Tagucchi, H., Irhey, Y. & Yasuraoka, K. (1991) Serologic and ultra-sonographic parameters of praziquantel treatment of hepatic fibrosis in Schistosoma japonicum infection. American Journal of Tropical Medicine and Hygiene 45, 350–359.
Sher, A., Pearce, E., Hieny, S. & James, S. (1986) Induction of protective immunity against Schistosoma mansoni by a non-living vaccine. IV Immunoprophylactic activity. Journal of Immunology 136, 3878–3883.
